Stem Cell Treatment for Chronic Fatigue Syndrome
Some people experience extreme fatigue. Even if they rest enough, the condition does not improve. Moreover, the condition worsens if he performs any activity. Such a complex disorder is called Chronic Fatigue Syndrome. With constant research and developments in the field of stem cell therapy, the quality of life of people suffering from this condition might be improved. Several medical clinics and research centers are using the own stem cells of the patients to treat Chronic Fatigue Syndrome.
What Causes Chronic Fatigue Syndrome?
The exact factor that leads to Chronic Fatigue Syndrome is unknown. However, it can generate due to any of the following factors, such as:
- Hormonal imbalance
- Elongated stress
- Abnormal blood pressure
- Immune impairment
- Viral infections
What are the Common Symptoms of Chronic Fatigue Syndrome?
It may not be possible to test chronic fatigue syndrome, but it can be characterized by:
- Permanent fatigue
- Muscular discomfort
- Loss of memory
- Sore throat
- Inexplicable headaches
- Active joint pain without swelling
- Enlarged lymph nodes
The most commonly affected age group that suffers from chronic fatigue syndrome is 40 to 50. However, it is possible that people of any age can be affected by this condition. Once affected, it complicates one’s regular activities, hampers daily routine and eventually leads to social isolation.
Stem Cell Therapy Chronic Fatigue Syndrome
Many studies show that mesenchymal stem cells (MSCs) administration can lessen the fatigue of people suffering from certain diseases like primary biliary cirrhosis. However, it is essential to consider that fatigue is subjective.
To a variety of conditions, MSC transmission has been well-tolerated, although results have been variable as a function of the delivery route. Also, the variability in cell potency between tissue sources, donors and culture conditions has been documented well.
For more details about Chronic Fatigue Syndrome Treatment with stem cell therapy, click below:
